标题
Clinical Advances of siRNA-Based Nanotherapeutics for Cancer Treatment
作者
关键词
-
出版物
Pharmaceutics
Volume 13, Issue 7, Pages 1009
出版商
MDPI AG
发表日期
2021-07-02
DOI
10.3390/pharmaceutics13071009
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells
- (2020) Hyun Jung Hwang et al. CANCER LETTERS
- Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
- (2020) Dima Hattab et al. Pharmaceutics
- Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment
- (2020) Giuseppina Roscigno et al. Cancers
- An Open‐Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM‐080301 in Subjects with Advanced Hepatocellular Carcinoma
- (2019) Imane El Dika et al. ONCOLOGIST
- Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy
- (2019) Faezeh Vakhshiteh et al. International Journal of Nanomedicine
- Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
- (2019) Anna A. Egorova et al. Pharmaceutics
- Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications
- (2019) Anna Angela Barba et al. Pharmaceutics
- Recent advances in nanotheranostics for triple negative breast cancer treatment
- (2019) Vikram Thakur et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
- (2019) Kenya Kamimura et al. Cancers
- Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer
- (2018) Karin Binnemars-Postma et al. FASEB JOURNAL
- Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis
- (2018) Ramon Handerson Gomes Teles et al. International Journal of Nanomedicine
- Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells
- (2018) Yudong Song et al. BIOMATERIALS
- RNA Interference-Based Cancer Drugs: The Roadblocks, and the “Delivery” of the Promise
- (2018) Manisit Das et al. Nucleic Acid Therapeutics
- Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles
- (2017) Jenny G Parvani et al. ENDOCRINE-RELATED CANCER
- Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)
- (2017) Michael J. Wagner et al. MOLECULAR CANCER THERAPEUTICS
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
- (2017) Sushrut Kamerkar et al. NATURE
- Tumor-targeted nanomedicines for cancer theranostics
- (2017) Alexandra G. Arranja et al. PHARMACOLOGICAL RESEARCH
- Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes
- (2017) Theresa L. Whiteside Translational Cancer Research
- Interim safety and pharmacodynamic results for ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
- (2017) J. Gollob et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement.
- (2017) A. Cervantes et al. JOURNAL OF CLINICAL ONCOLOGY
- Recent progress in development of siRNA delivery vehicles for cancer therapy
- (2016) Hyun Jin Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
- (2016) Fahimeh Shahabipour et al. Archives of Medical Science
- An open-label, multi-center, phase I/II, dose escalation study of IV TKM-080301 in subjects with advanced hepatocellular carcinoma
- (2016) G.K. Abou-Alfa et al. EUROPEAN JOURNAL OF CANCER
- Progress and perspective of inorganic nanoparticle-based siRNA delivery systems
- (2016) Ying Jiang et al. Expert Opinion on Drug Delivery
- Lipid nanoparticles for targeted siRNA delivery – going from bench to bedside
- (2016) Victor Kotelianski et al. International Journal of Nanomedicine
- A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.
- (2016) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy
- (2016) Yuval Ramot et al. TOXICOLOGIC PATHOLOGY
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- 15 years on siRNA delivery: Beyond the State-of-the-Art on inorganic nanoparticles for RNAi therapeutics
- (2015) João Conde et al. Nano Today
- Clinical overview of metronomic chemotherapy in breast cancer
- (2015) Elisabetta Munzone et al. Nature Reviews Clinical Oncology
- Clinical experiences with systemically administered siRNA-based therapeutics in cancer
- (2015) Jonathan E. Zuckerman et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
- (2015) Xiaoqi Liu Translational Oncology
- RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients
- (2015) Talia Golan et al. Oncotarget
- Abstract LB-289: A phase I dose escalation study of TKM-080301, a RNAi therapeutic directed against PLK1, in patients with advanced solid tumors.
- (2014) Ramesh K. Ramanathan et al. CANCER RESEARCH
- First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors
- (2014) Beate Schultheis et al. JOURNAL OF CLINICAL ONCOLOGY
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
- (2014) Trinna L. Cuellar et al. NUCLEIC ACIDS RESEARCH
- Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
- (2014) J. E. Zuckerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Investigating the optimal size of anticancer nanomedicine
- (2014) L. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RNAi Therapies: Drugging the Undruggable
- (2014) S. Y. Wu et al. Science Translational Medicine
- Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
- (2014) Kathryn A. Whitehead et al. Nature Communications
- Development of siRNA Payloads to Target KRAS-Mutant Cancer
- (2014) T. L. Yuan et al. Cancer Discovery
- Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics
- (2014) Cheol Am Hong et al. Theranostics
- L03.04 * ANTIMETASTATIC ACTIVITY OF ATU027, A LIPOSOMAL SIRNA FORMULATION, TARGETING PROTEIN KINASE N3: FINAL RESULTS OF A PHASE I STUDY
- (2013) D. Strumberg et al. ANNALS OF ONCOLOGY
- Molecular Mechanisms of RNA Interference
- (2013) Ross C. Wilson et al. Annual Review of Biophysics
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
- (2013) Martin A Maier et al. MOLECULAR THERAPY
- Heterogeneity in nanoparticles influences biodistribution and targeting
- (2013) Isaac M Adjei et al. Nanomedicine
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Mutant KRAS is a druggable target for pancreatic cancer
- (2013) E. Zorde Khvalevsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement
- (2013) Josep Tabernero et al. Cancer Discovery
- Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
- (2012) Mohammad Aminur Rahman et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle Hydrophobicity Dictates Immune Response
- (2012) Daniel F. Moyano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Assessing the Heterogeneity Level in Lipid Nanoparticles for siRNA Delivery: Size-Based Separation, Compositional Heterogeneity, and Impact on Bioperformance
- (2012) Jingtao Zhang et al. MOLECULAR PHARMACEUTICS
- Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
- (2011) Dirk Strumberg et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- siRNA Knockdown of Ribonucleotide Reductase Inhibits Melanoma Cell Line Proliferation Alone or Synergistically with Temozolomide
- (2010) Jonathan E. Zuckerman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Gold Nanoparticles Capped with Polyethyleneimine for Enhanced siRNA Delivery
- (2009) Wen-Jing Song et al. Small
- Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
- (2008) M. Aleku et al. CANCER RESEARCH
- Chemical Modification of siRNAs for In Vivo Use
- (2008) Mark A. Behlke OLIGONUCLEOTIDES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now